Search Results - "Price, J T"

Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research by Grover, P.K., Cummins, A.G., Price, T.J., Roberts-Thomson, I.C., Hardingham, J.E.

“…Increasing evidence suggests that circulating tumour cells (CTCs) are responsible for metastatic relapse and this has fuelled interest in their detection and…”
Get full text

Semiclassical Treatment of High-Lying Electronic States of H2 by Price, T. J, Greene, Chris H

“…We report quantum-mechanical and semiclassical WKB calculations for energies and wave functions of high-lying 2Σ states of H2 + in atomic units. The high-lying…”
Get full text

Rovibrational Transitions in HCl due to Collisions with H2: Spin-free and Hyperfine-resolved Transitions by Hoffman, Daniel, Taylor, Josiah, Price, T. J., Forrey, Robert C., Yang, B. H., Stancil, P. C., Zhang, Z. E., Balakrishnan, N.

“…Hydrogen chloride (HCl) is a key repository of chlorine in the interstellar medium. Accurate determinations of its abundance are critical to assessing the…”
Get full text

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer by Peeters, M., Price, T.J., Cervantes, A., Sobrero, A.F., Ducreux, M., Hotko, Y., André, T., Chan, E., Lordick, F., Punt, C.J.A., Strickland, A.H., Wilson, G., Ciuleanu, T.E., Roman, L., Van Cutsem, E., Tian, Y., Sidhu, R.

“…The study 20050181 demonstrated significant improvements in progression-free survival (PFS), objective response, and a nonsignificant trend toward increased…”
Get full text

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer by Jonker, D J, Karapetis, C S, Harbison, C, O'Callaghan, C J, Tu, D, Simes, R J, Malone, D P, Langer, C, Tebbutt, N, Price, T J, Shapiro, J, Siu, L L, Wong, R P W, Bjarnason, G, Moore, M J, Zalcberg, J R, Khambata-Ford, S

“…Background: Anti-EGFR antibody, cetuximab, improves overall survival (OS) in K-ras wild-type chemotherapy–refractory colorectal cancer. Epidermal growth factor…”
Get full text

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines by Ransom, D., Wilson, K., Fournier, M., Simes, R.J., Gebski, V., Yip, D., Tebbutt, N., Karapetis, C.S., Ferry, D., Gordon, S., Price, T.J.

“…Cardiac toxicity an uncommon but serious side-effect of some fluoropyrimides. Cardiac toxicity from raltitrexed is rarely reported. With this background, we…”
Get full text

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C by Price, T.J., Zannino, D., Wilson, K., Simes, R.J., Cassidy, J., Van Hazel, G.A., Robinson, B.A., Broad, A., Ganju, V., Ackland, S.P., Tebbutt, N.C.

“…In an ageing population, a greater proportion of geriatric patients will be considered for systemic chemotherapy. Colorectal cancer (CRC) is a common…”
Get full text

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer by Weickhardt, A J, Williams, D S, Lee, C K, Chionh, F, Simes, J, Murone, C, Wilson, K, Parry, M M, Asadi, K, Scott, A M, Punt, C J A, Nagtegaal, I D, Price, T J, Mariadason, J M, Tebbutt, N C

“…Background: Bevacizumab prolongs progression-free survival (PFS) in patients with metastatic colorectal cancer. We analysed the protein expression levels of…”
Get full text

The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials by Segelov, E, Chan, D, Shapiro, J, Price, T J, Karapetis, C S, Tebbutt, N C, Pavlakis, N

“…Purpose: Biologic agents have achieved variable results in relapsed metastatic colorectal cancer (mCRC). Systematic meta-analysis was undertaken to determine…”
Get full text

Self-injurious behaviour in intellectual disability syndromes: evidence for aberrant pain signalling as a contributing factor by Peebles, K. A., Price, T. J.

“…Background  In most individuals, injury results in activation of peripheral nociceptors (pain‐sensing neurons of the peripheral nervous system) and…”
Get full text

Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity by Walczak, J.S, Price, T.J, Cervero, F

“…Abstract Pharmacological studies have indirectly shown the possible presence of cannabinoid receptors in the urinary bladder and their potential role in…”
Get full text

Do metastatic colorectal cancer patients who present with late relapse after curative surgery have a better survival? by Broadbridge, V T, Karapetis, C S, Beeke, C, Woodman, R J, Padbury, R, Maddern, G, Kim, S W, Roder, D, Hakendorf, P, Price, T J

“…Background: Patients who relapse after potentially curative surgery for colorectal cancer tend to relapse within 5 years. There is, however, a group of…”
Get full text

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer by Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N., Jefford, M.

“…Purpose Psychological responses to cancer are widely believed to affect survival. We investigated associations between hope, optimism, anxiety, depression,…”
Get full text

Possible CO2 mitigation via addition of charcoal to coking coal blends by MACPHEE, J. A, GRANSDEN, J. F, GIROUX, L, PRICE, J. T

“…Processes involving biomass oxidation are considered to be CO2 neutral since the replenishing of the biomass by normal growth will remove CO2 from the…”
Get full text

Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab by Tebbutt, N.C., Murphy, F., Zannino, D., Wilson, K., Cummins, M.M., Abdi, E., Strickland, A.H., Lowenthal, R.M., Marx, G., Karapetis, C., Shannon, J., Goldstein, D., Nayagam, S.S., Blum, R., Chantrill, L., Simes, R.J., Price, T.J.

“…Bevacizumab is an antiangiogenic mAb with efficacy against several cancers, but it is associated with risk of arterial thromboembolism (ATE). Further data are…”
Get full text

Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17 by Vickers, M.M., Karapetis, C.S., Tu, D., O'Callaghan, C.J., Price, T.J., Tebbutt, N.C., Van Hazel, G., Shapiro, J.D., Pavlakis, N., Gibbs, P., Blondal, J., Lee, U., Meharchand, J.M., Burkes, R.L., Rubin, S.H., Simes, J., Zalcberg, J.R., Moore, M.J., Zhu, L., Jonker, D.J.

“…Cetuximab-induced hypomagnesemia has been associated with improved clinical outcomes in advanced colorectal cancer (CRC). We explored this relationship from a…”
Get full text

The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat by Price, T.J, Helesic, G, Parghi, D, Hargreaves, K.M, Flores, C.M

“…Cannabinoid compounds have been shown to produce antinociception and antihyperalgesia by acting upon cannabinoid receptors located in both the CNS and the…”
Get full text

Implementation and feasibility of an adapted two-stage visual inspection with acetic acid/cryotherapy-based cervical cancer screening programme for HIV-infected women in Addis Ababa, Ethiopia by Price, J.T., Asgary, R.

Get full text

Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan by CHONG, G, DICKSON, J. L. B, CUNNINGHAM, D, NORMAN, A. R, RAO, S, HILL, M. E, PRICE, T. J, OATES, J, TEBBUTT, N

“…Protracted venous infusion 5-fluorouracil (5FU) combined with mitomycin C (MMC) has demonstrated significant activity against metastatic colorectal cancer…”
Get full text

The RNA binding and transport proteins staufen and fragile X mental retardation protein are expressed by rat primary afferent neurons and localize to peripheral and central axons by Price, T.J., Flores, C.M., Cervero, F., Hargreaves, K.M.

“…Neuronal proteins have been traditionally viewed as being derived solely from the soma; however, accumulating evidence indicates that dendritic and axonal…”
Get full text